Skip to main content
. 2021 Sep 24;9(9):23259671211035384. doi: 10.1177/23259671211035384

Table 2.

Study Characteristics a

Lead Author Age, y
Mean ± SD (range)
Site of Lesion, % Follow-up, y
Mean ± SD (range)
N Sex (M/F), n Prior Cartilage Procedures Defect Size, cm2,
Mean ± SD (range)
Workers’ Compensation, n (%)
Minas 20 35 ± 9.2 (13-60) a 35.4 ± 10.1 (14-55) b 4.5 ± 2.3 (2-11) a
4.7 ± 2.5 (2-12) b
325 185/136 MFX (n = 25)
AA (n = 33)
Drill (n = 53)
4.6 ± 2.7 (0.5-21) a
5.2 ± 3.1 (0.7-16.8) b
28 (13) a
24 (22) b
Zaslav 41 35.5 ± 8.6 a
32.9 ± 7.6 b
MFC (64-68)
LFC (16-18)
Troch (16-18)
3.8 ± 2.4 143 106/48 MFX (n = 42)
Drill (n = 16)
Other (n = 2)
AA (n = 9)
4.7 ± 2.1 a
4.6 ± 4.1 b
Riff  33 30.4 ± 9.4 a
30.3 ± 9 (14.9-49.9) b
MFC (29-38)
LFC (10-18)
Troch (25-28)
Pat (19-25)
3.6 ± 1.7 a
3.9 ± 2.0 b
192 102/90 BMS 5.0 a
5.0 b
24 (25) a
23 (25) b
Müller 23 32.9 ± 11.8 (16-55) a
39.1 ± 10 (19-53) b
Femoral (50-55)
Pat (40-45)
Troch (5)
3 40 14/26 BMS 5.4 ± 2.6 (2-15) a
4.8 ± 2 (2-10) b
Pestka 32 33.6 ± 10.1 (19.2-54.2) a
34.1 ± 9 (14.8-45.8) b
MFC (57.1)
LFC (7.1)
Troch (2)
Pat (10.7)
3.5 ± 1.4 (1.3-7) a
4 ± 1.4 (1.3-6.3) b
55 32/24 MFX (n = 28) 4.7 ± 1.6 (2.5-9.0) a
4.6 ± 2.7 (1.5-7.5) b
Jungmann 15 34.9 ± 9.0 4.4 ± 0.9 (2-11.8) 383 237/176 BMS 5.6 ± 3.0
Ogura 26 36.6 ± 9.2 (16-55) Bipolar PF (100) 8.8 ± 4.2 (2-16) 60 34/22 BMS 10.2 ± 4.1 (2.7-19.7)
Beck 4 18.3 ± 0.2 (15-22) MFC (60)
LFC (40)
12 ± 4.5 10 5/5 BMS 9.1 ± 2.0 (2.3-24)
Ogura 29 35.4 ± 10.4 (13-52) 20.6 ± 0.3 (20-21) 24 16/7 BMS 11.8 ± 8 (2.4-30.5) 8 (33)
Minas 21 35.8 ± 9.6 (8-57) 12 ± 2 210 113/97 MFX (n = 13)
AA (n = 30)
Drill (n = 46)
8.4 ± 5.5 46 (22)
Pascual-Garrido 31 31.8 ± 8.6 4 (2-7) 37 26/26 MFX 4.2 ± 1.6

a Control group. Dashes indicate data was not available. AA, abrasion arthroplasty; BMS, bone marrow stimulation; LFC, lateral femoral condyle; M/F, male/female; MFC, medial femoral condyle; MFX, microfracture; Pat, patella; PF, patellofemoral; Troch, trochlea.

b BMS group.